Drugs / HM30181A-US
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03544567 | Dec 2018 → May 2023 | skin angiosarcoma | Athenex, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HM30181A-US | “oral paclitaxel will be supplied in capsules and oral HM30181A-US in tablets” NCT03544567 ↗ |
| Route | Oral | “oral paclitaxel will be supplied in capsules and oral HM30181A-US in tablets” NCT03544567 ↗ |